Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Boldyreff, B.
Right arrow Articles by Wehling, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boldyreff, B.
Right arrow Articles by Wehling, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 1693-1695
© 2003 European Renal Association-European Dialysis and Transplant Association


Editorial Comment

Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells

Brigitte Boldyreff and Martin Wehling

Department of Clinical Pharmacology, Faculty of Clinical Medicine Mannheim, Heidelberg University, Mannheim, Germany

Correspondence and offprint requests to: Martin Wehling, MD, Department of Clinical Pharmacology, Faculty of Clinical Medicine Mannheim, Heidelberg University, Theodor-Kutzer Ufer 1-3, D-68167 Mannheim, Germany. Email: martin.wehling@kpha.ma.uni-heidelberg.de

Keywords: aldosterone; early induced genes; kidney; non-genomic effects; renal disease

The first 10% of the full text of this article appears below.

Introduction

Steroid-hormone action in the classical sense means binding to intracellular receptors, binding of the hormone–receptor complex to DNA and activation or repression of transcription of target genes. However, all classes of steroid hormones can additionally act through non-genomic mechanisms and thereby change physiological processes [1]. In contrast to genomic steroid actions, these non-genomic effects are characterized with rapid onset and insensitivity towards inhibitors of transcription and translation. Non-genomic effects of aldosterone on various target organs and cells have been described, i.e. vascular smooth muscle cells and endothelial cells [2], skeletal muscle cells [3], lymphocytes [4], cardiac myocytes [5], colonic epithelial cells [6] and kidney cells [7]. In the classical target organ, the kidney, aldosterone stimulates Na+ (re)absorption and K+ secretion through both mechanisms, genomic as well as non-genomic [8].

Mechanisms involved in non-genomic aldosterone action

. . . [Full Text of this Article]

Crosstalk between non-genomic and genomic aldosterone actions

Aldosterone as a mediator of renal dysfunction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
S. Bunda, P. Liu, Y. Wang, K. Liu, and A. Hinek
Aldosterone Induces Elastin Production in Cardiac Fibroblasts through Activation of Insulin-Like Growth Factor-I Receptors in a Mineralocorticoid Receptor-Independent Manner
Am. J. Pathol., September 1, 2007; 171(3): 809 - 819.
[Abstract] [Full Text] [PDF]